Apply This IPO

Best Margin

Zero Brokerage

24*7 Customer Support.

Fastest mobile support

---

Apply with Angel One

Apply with Zerodha

Pre-Apply with Upstox

Emcure Pharmaceuticals Limited IPO Review

Emcure Pharmaceuticals Limited IPO was engaged in are an Indian pharmaceutical company focused on creating, producing, and selling a wide variety of medicines around the world. Their company is driven by research and development (R&D), and they offer a unique range of products including pills, injections, and biotherapeutics. This has allowed them to successfully reach target markets in more than 70 countries, with a significant presence in India, Europe, and Canada. For the MAT Financial Year 2024, they were ranked as the 13th largest pharmaceutical company in India based on domestic sales. In their specific markets, they achieved the position of the 4th largest pharmaceutical company by market share. Additionally, they were recognized as the leading pharmaceutical company in India for gynecology and HIV antiviral treatments based on domestic sales.

They have organized their operations so that their acute and chronic (including sub-chronic) therapeutic area businesses are mostly managed by different teams. They use specific strategies for their acute and chronic products since they need different approaches and marketing strengths. Most of their chronic business is run directly by their company, while most of their acute business is managed by their subsidiary, Zuventus Healthcare Limited.Top of FormBottom of Form

Emcure Pharmaceuticals Limited Products and Services

They have organized their operations so that their acute and chronic (including sub-chronic) therapeutic area businesses are mostly managed by different teams. They use specific strategies for their acute and chronic products since they need different approaches and marketing strengths. Most of their chronic business is run directly by their company, while most of their acute business is managed by their subsidiary, Zuventus Healthcare Limited.

Emcure Pharmaceuticals Limited Products and service are well-placed to Leverage their Position in the Domestic Market, Demonstrated Capabilities of Building Brands, Large, Diversified and Fast-Growing Product Portfolio in International Markets, Highly Qualified, Experienced and Entrepreneurial Management Team and Board.

Financial Overview

The company is a leading pharmaceutical firm with specialized products, serving markets worldwide. It saw an increase in revenue, but profits declined due to higher interest and depreciation costs. Based on FY24 earnings, the stock seems fairly valued. Reducing debt after the IPO will improve profits accordingly. Investors might consider investing for the medium to long term.